Valeant Pharmaceuticals International

Type: Company
Name: Valeant Pharmaceuticals International
First reported 14 hours ago - Updated 5 hours ago - 2 reports

ACNEFREE CLEAR SKIN TREATMENTS ADVANCED DEEP CLEANSING DUO (Benzoyl Peroxide) Kit [Valeant Pharmaceuticals North America LLC]

First reported 16 hours ago - Updated 13 hours ago - 2 reports

Ominous Signs For Valeant In The Allergan Q2 Earnings Call

Summary Allergan's CEO looks set to make an acquisition. I haven't seen him this open-minded and aggressive about acquisitions before. He is confident of making his moves before any special meeting. EPS benefit from any acquisition made by Allergan ... [Published Seeking Alpha - 13 hours ago]
First reported 20 hours ago - Updated 15 hours ago - 1 reports

Globe says Valeant ally Ackman's attack flops in N.Y.

The Globe and Mail reports in its Wednesday edition hedge fund manager Bill Ackman unleashed a new salvo of accusations against Herbalife International, but failed to persuade investors to ditch the company's shares.The Globe's Joanna Slater writes during ... [Published Stockwatch - 20 hours ago]
First reported Jul 22 2014 - Updated 19 hours ago - 16 reports

B+L owner contacts SEC over Allergan claims

Bausch+Lomb owner Valeant Pharmaceuticals International has complained to authorities regarding statements made by its latest acquisition target Allergan.Valeant contacted the Autorite des marches financiers in Quebec and the US Securities and Exchange ... [Published Optician Online - 19 hours ago]
First reported Jul 22 2014 - Updated Jul 23 2014 - 1 reports

In brief: Verizon’s upload speeds to match downloads

Verizon is boosting the upload speeds of nearly all its FiOS connections to match the download speeds, vastly shortening the time it takes for subscribers to send videos and back up their files online. All new subscribers now will get “symmetrical” connections. ... [Published Omaha World-Herald - Jul 22 2014]
First reported Jul 23 2014 - Updated Jul 23 2014 - 1 reports

Business brief: Consumer confidence highest since 2007

MORE than half of the world's consumers expect job prospects to be good to excellent in the year ahead, a survey showed. MORE than half of the world's consumers expect job prospects to be good to excellent in the year ahead, a survey showed. Consumer ... [Published Irish Independent - Jul 23 2014]
First reported Jul 22 2014 - Updated Jul 22 2014 - 7 reports

Valeant Pharmaceuticals complains to SEC over Allergan claims

[embedded content]Valeant Pharmaceuticals  has complained to securities regulators that claims made by  Allergan  to counter a hostile takeover bid are misleading and manipulative, sources have told CNBC.Adam Jeffery | CNBCMichael Pearson, CEO of Valeant ... [Published NBR.com - Jul 22 2014]
First reported Jul 22 2014 - Updated Jul 22 2014 - 1 reports

Globe says Valeant buddy Ackman takes aim at Herbalife

The Globe and Mail reports in its Tuesday edition Herbalife shares took a hit Monday after hedge-fund player Bill Ackman vowed toshow Enron-like fraud atthe maker of supplements andweight-loss shakes. A Bloomberg dispatch to The Globe says Mr. Ackman, ... [Published Stockwatch - Jul 22 2014]
First reported Jul 22 2014 - Updated Jul 22 2014 - 1 reports

Valeant Pharmac. (VRX) Showing Resistance Near $129.72

MarketIntelligenceCenter.com's patented algorithms have identified an attractive covered-call trade on Valeant Pharmac. (VRX). Look at the Sep. '14 $125.00 covered call for a net debit in the $118.94 area. This trade has a duration of 60 days. The break-even ... [Published MarketIntelligenceCenter.com - Jul 22 2014]
First reported Jul 22 2014 - Updated Jul 22 2014 - 1 reports

Start your vacation on the right foot

Valeant Canada introduces Jublia TM for the treatment of fungal infections of toenailsLAVAL, QC , July 22, 2014 /CNW Telbec/ - Valeant Canada is proud to announce the arrival of Jublia TM , an improved treatment for fungal infections of toenails. Onychomycosis ... [Published Stockboard Media Inc. - Jul 22 2014]
First reported Jul 22 2014 - Updated Jul 22 2014 - 8 reports

Valeant takes Allergan's 'false and misleading statements' to Quebec and US financial regulators

In the latest in an ongoing  takeover attempt of Allergan (NYSE: AGN) by Canadian company Valeant (NYSE: VRX), Valeant has contacted financial authorities in both Quebec and the USA regarding Allergan’s apparent attempt to mislead investors and manipulate ... [Published Pharma Letter - Jul 22 2014]
First reported Jul 22 2014 - Updated Jul 22 2014 - 4 reports

Allergan to Lay Off 13% of Workforce, Cut Drug Research

As drug maker Allergan Inc. tries to avoid being acquired, it is taking a page from its pursuer, Valeant Pharmaceuticals International Inc. The Botox maker said Monday it is laying off workers and cutting drug research—exactly what Valeant said it would ... [Published DailyMe.Com - Jul 22 2014]

Quotes

...that the Corporation Finance division will "continue to consider issues raised by the filing related to the abandoned shareholder referendum" and "issues raised by any future filings of a similar nature."
...fragmentation clearance on the VICTUS platform further strengthens our offerings," said Calvin Roberts , M D , chief medical officer, Bausch + Lomb. "For cataract, refractive or retinal surgery, the more you look at Bausch + Lomb, the more you'll see that we have the platforms, intraocular lenses, instruments, packs, and distribution partnerships that together are helping improve patients' vision and eye health."
"Generic drug inventories that have been plentiful for years suddenly won't be available for a time," he said. "When they come back on the market, the price is exorbitant compared to what it used to be."
"...we are going to have a shareholder vote and this deal will be done"

More Content

All (2001) | News (1394) | Reports (0) | Blogs (555) | Audio/Video (17) | Fact Sheets (2) | Press Releases (31)
sort by: Date | Relevance
Republican lawmaker to grill U.S. SEC over Ackm... [Published CNBC - 5 hours ago]
ACNEFREE CLEAR SKIN TREATMENTS ADVANCED DEEP CL... [Published DailyMed Drug Label Updates for the last seven ... - 5 hours ago]
Bausch + Lomb's VICTUS® Femtosecond Laser Platf... [Published 4 Traders - 9 hours ago]
Biggest Movers in Healthcare Stocks Now – ARIA ... [Published InvestorPlace.com - 9 hours ago]
PHARMACEUTICAL STICKER SHOCK ; Prices of generi... [Published Insurance News Net - 11 hours ago]
Ominous Signs For Valeant In The Allergan Q2 Ea... [Published Seeking Alpha - 13 hours ago]
ACNEFREE CLEAR SKIN TREATMENTS ADVANCED DEEP CL... [Published DailyMed Drug Label Updates for the last seven ... - 14 hours ago]
Bill Ackman$$$s 2014 Gains May Give Time to Her... [Published Leavenworth Times - 15 hours ago]
Bill Ackman’s 2014 Gains May Give Time to Herba... [Published TheStreet.com - 15 hours ago]
Bill Ackman’s 2014 Gains May Give Time to Herba... [Published The Street Latest - 15 hours ago]
Ackman Says Valeant-Allergan Deal Looking Up [Published FINalternatives - 16 hours ago]
B+L owner contacts SEC over Allergan claims [Published Optician Online - 19 hours ago]
Globe says Valeant ally Ackman's attack flops i... [Published Stockwatch - 20 hours ago]
Valeant Pharmac. (VRX) Trading Near $118.62 Sup... [Published MarketIntelligenceCenter.com - 21 hours ago]
Allergan to Cut 13% of Jobs in Fight Against Va... [Published CHEManager - 22 hours ago]
Allergan Sales Rose Nearly 16 Percent in Second... [Published Vision Monday - Jul 23 2014]
Allergan Releases Comments on Pershing Square's... [Published Individual.com - Jul 23 2014]
Battle between Allergan & Valeant heats up [Published Stockboard Media Inc. - Jul 23 2014]
Business brief: Consumer confidence highest sin... [Published Irish Independent - Jul 23 2014]
Allergan employees have mixed emotions as layof... [Published Los Angeles Times - Jul 23 2014]
Canadian stock market rallies on strong earning... [Published Individual.com - Jul 22 2014]
Argentina Just Played Its Final Card... And It ... [Published Business Insider - Jul 22 2014]
'Valeant-Lite' Derided as Valeant Cries Foul [Published The Big Red Biotech Blog - Jul 22 2014]
Investment Analysts’ New Coverage for July, 22n... [Published American Banking News - Jul 22 2014]
BTIG: Valeant Must Sweeten Allergan Bid To More... [Published Street Sweeper - Jul 22 2014]
BTIG: Valeant Must Sweeten Allergan Bid To More... [Published Minyanville - Jul 22 2014]
Valeant Pharmaceuticals Intl Now Covered by Ana... [Published American Banking News - Stock Ratings - Jul 22 2014]
BTIG: Valeant Must Sweeten Allergan Bid To More... [Published Benzinga.com - Jul 22 2014]
Allergan, a Valeant Takeover Target, Plans 1,50... [Published Yahoo! Finance - Jul 22 2014]
Allergan to slash 1,500 jobs as it defends agai... [Published GlobeAdvisor - Jul 22 2014]
1 2 3 4 5 6 7 8 9 10 ...
In Focus
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
Content Volume
Document Volume
Network
Network

Blogs

sort by: Date | Relevance
ACNEFREE CLEAR SKIN TREATMENTS ADVANCED DEEP CL... [Published DailyMed Drug Label Updates for the last seven ... - 5 hours ago]
Updated Date: Jul 23, 2014 EST ...
ACNEFREE CLEAR SKIN TREATMENTS ADVANCED DEEP CL... [Published DailyMed Drug Label Updates for the last seven ... - 14 hours ago]
Updated Date: Jul 23, 2014 EST ...
Valeant Pharmac. (VRX) Trading Near $118.62 Sup... [Published MarketIntelligenceCenter.com - 21 hours ago]
After Tuesday’s trading in Valeant Pharmac. (VRX) the algorithms behind MarketIntelligenceCenter.com's Artifical Intelligence Center picked out a trade that offers a 4.77% or 29.49% (for comparison purposes only), while providing 6.53% downside protection. ...
'Valeant-Lite' Derided as Valeant Cries Foul [Published The Big Red Biotech Blog - Jul 22 2014]
Well, yesterday Allergan beat Valeant to the punch so to speak when it announced that it would be cutting 1500 (primarily) R&D discovery jobs and not filling 250 open positions in a cost cutting move aimed at boosting shareholder value = code for keeping ...
Valeant Pharmac. (VRX) Showing Resistance Near ... [Published MarketIntelligenceCenter.com - Jul 22 2014]
MarketIntelligenceCenter.com's patented algorithms have identified an attractive covered-call trade on Valeant Pharmac. (VRX). Look at the Sep. '14 $125.00 covered call for a net debit in the $118.94 area. This trade has a duration of 60 days. The break-even ...
1 2 3 4 5 6 7 8 9 10 ...

Audio/Video

sort by: Date | Relevance
Financial Stocks Help Lift The Major Indexes [Published Wall Street Journal What's News - Jun 17 2014]
Breakingviews: Snapchat for bankers? [Published Reuters Video: Top News - Jun 16 2014]
Breakingviews: Snapchat for bankers? [Published Reuters Video: Business - Jun 16 2014]
The Market Takes A Breather [Published Wall Street Journal What's News - Jun 10 2014]
Breakingviews: Valeant's deceptive carrot [Published Reuters Video: Business - Jun 02 2014]
1 2 3 4

Press Releases

sort by: Date | Relevance
Valeant Pharmaceuticals Contacts Quebec and U.S... [Published Financial Services - Jul 21 2014]
Health Care Sector Stocks Technical Review: Val... [Published Financial Services - Jul 17 2014]
Valeant Pharmaceuticals Completes Sale Of Fille... [Published Financial Services - Jul 10 2014]
Valeant Pharmaceuticals Completes Acquisition O... [Published Financial Services - Jul 08 2014]
Scheduled Conference Calls, License Agreements,... [Published Financial Services - Jun 30 2014]
1 2 3 4 5 6 7
Contact Us
Sales
Support


Freebase CC-BY Some image thumbnails are sourced from Freebase, licensed under CC-BY

Copyright (C) 2014 Silobreaker Ltd. All rights reserved.
The selection and placement of stories and images on any Silobreaker page are determined automatically by a computer program.
The time or date displayed reflects when an article was added to or updated in Silobreaker.